Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, May 26, 2026

Snapshot: May 26, 2026 · 6:00 PM 100 stocks analyzed

Up Day

Tue, May 26, 2026 Small-Cap Rally High

Small-cap surge powered by micro-cap explosions and biotech optimism; Russell 2000 outpaced S&P by 117 bps in a high-dispersion rally with YMAT up 203% on sovereign battery fina…

60% Small-cap leadership dominated the tape as Russell 2000 gained 1.79% versus S&P 500's 0.62%, driven by a wave of micro-cap explosions including YMAT's 203% surge on Taiwan sovereign battery facility backing, MNTS up 110% on space sector momentum, and five first-time appearances among the top 50 gainers signaling fresh retail appetite for beaten-down names.
25% High dispersion and extreme single-stock volatility characterized the day, with 50 gainers averaging +46% and 50 losers averaging -20%, while Healthcare bore the brunt on the sell side at 30% of losers and CODX extended a six-day winning streak with a 80% jump on Ebola test expansion news alongside new partnerships from BRAI and SNGX driving biotech optimism.
15% Broad risk appetite persisted despite modest VIX uptick of +2.5% to 17.01, as NASDAQ climbed 1.19% and major sectors like Technology and Financial Services balanced equally in the gainers (26% and 26% share respectively), while strategic capital allocation announcements from HTT, UZX, and Vicor raised guidance, signaling management confidence in underlying business momentum.

Healthcare drove 30% of losers CODX on a 6-day gainers streak 5 names returned after long absences CODX · 6-day gainers streak YYGH · 6-day losers streak AIMD — first appearance

Market Regime

Tue, May 26, 2026 Risk-On conf: high macro · prototype

+35

Tailwind −100 … +100 · + tailwind / − headwind

VIX17.0 p47 Drawdown0.0% Held4d · building SinceMay 21

Top drivers: S&P vs 50d avg ▲ S&P 20d return ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Tue, May 26, 2026 4

S&P 500

7,519.47

+46.00

+0.62%

NASDAQ Composite

26,656.18

+312.21

+1.19%

Russell 2000

2,920.54

+51.31

+1.79%

VIX

17.01

+0.42

+2.53%

Biggest Gainers

Tue, May 26, 2026 50

YMAT

J-Star Holding Co., Ltd. Ordinary SharesBasic Materials

$1.38+$0.92

+203.2%

NASDAQ · Mkt cap $7.3 M

J-Star Holding's Taiwan subsidiary secured Central Bank authorization for a $60 million sovereign-backed financing framework to fund a $122.5 million solid-state battery manufacturing facility in Texas, likely triggering the 203% surge on institutional confidence in the project's backing.

The company announced on May 26 that its subsidiary received authorization from Taiwan's Central Bank to establish a financing framework through designated banks. This framework supports development of an advanced battery manufacturing facility in Baytown, Texas valued at $122.5 million. The presence of central bank authorization and sovereign backing typically signals material risk reduction and capital availability for a micro-cap stock like YMAT, which may have been trading illiquidly beforehand. The solid-state battery sector carries significant growth expectations, and institutional-grade financing from a foreign government central bank carries credibility that can unlock retail and institutional demand. However, the headlines do not specify funding terms, disbursement schedule, or equity dilution details that would normally accompany such announcements, leaving some gaps in the full story.

VCIG

VCI Global LimitedIndustrials

$2.90+$1.57

+118.0%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours, so the 118% gain cannot be attributed to a specific announced event. The jump likely reflects either technical buying, a delayed market reaction to older news, or speculation in this lower-priced NASDAQ stock.

The absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for VCIG's dramatic 118% single-day gain. For a stock at this price level, moves of this magnitude can occur from several sources: a short squeeze or technical breakout after accumulation, retail buying momentum, options-related hedging or gamma effects, or a delayed market reaction to earnings or corporate actions released outside the standard news cycle. Without access to the company's recent press releases, SEC filings, insider activity, or broader context about its capital structure and float, I cannot rule out any of these mechanisms. The stock's rank as the second-biggest gainer suggests broad trading interest, but that alone does not identify the underlying cause.

MNTS

Momentus Inc.Industrials

$15.48+$8.10

+109.8%

NASDAQ · Mkt cap $80 M

Momentus surged 109.76% on the back of broad space sector momentum triggered by SpaceX's IPO filing, with company-specific positive developments also cited as contributing factors to the micro-cap stock's rally.

The headlines establish that a space sector-wide rally occurred on May 26, 2026, following SpaceX's IPO prospectus filing. Momentus, as a micro-cap player in the commercial space industry, benefited from this sector tailwind. One headline specifically mentions that Momentus surged 20% overnight due to "company-specific positive developments" combined with "growing sector momentum," but the news sources provided do not detail what those company-specific developments are. The jump from 20% overnight to 109.76% by day's end suggests either additional intraday news broke (not captured in the provided headlines) or the sector momentum accelerated sharply. The move is consistent with how small-cap stocks can experience outsized gains during broad sector rallies, particularly in growth-oriented industries like commercial spaceflight.

QTEX

Inspira Technologies Oxy B.H.N. Ltd.Technology

$1.52+$0.79

+109.1%

NASDAQ · Mkt cap $50 M

No news headlines were found in the last 48 hours, so the 109% surge in QTEX cannot be attributed to a specific announced catalyst; the move likely reflects technical factors, delayed news dissemination, or market rumors.

Inspira Technologies is a small-cap medical device company listed on NASDAQ, and the complete absence of news in the RSS feed within 48 hours of a massive 109% single-day gain is notable. For a stock of this size and liquidity profile, such moves are typically driven by either a significant company announcement (clinical trial results, regulatory approval, partnership, funding), short-covering in a thinly traded name, or broad sector rotation. Without headline evidence, the most probable explanations are either that relevant news was not captured in the Yahoo Finance feed, a technical or short-squeeze dynamic pushed the stock higher on low volume, or news broke outside the standard newswire window. Biotech and medical device stocks are particularly prone to large single-day moves on clinical or regulatory milestones, so if QTEX did announce something material in the past 48 hours, that would be the leading hypothesis.

AIMD

Ainos, Inc.Technology

$3.16+$1.63

+106.5%

NASDAQ · Mkt cap $11 M

AIMD surged 106.54% with no news headlines detected in the last 48 hours, suggesting the move was driven by technical factors, a delayed announcement, or market speculation rather than a reported corporate event.

The absence of any Yahoo Finance headlines in the past 48 hours makes it impossible to attribute this dramatic 106% gain to a specific disclosed event such as earnings, clinical trial results, FDA approval, partnership announcement, or guidance change. For a small-cap biotech or medical device stock like Ainos trading at $3.16, large single-day moves without concurrent news coverage typically reflect one or more of the following: a significant short squeeze or gamma-driven rally from options activity, social media momentum or retail trading flows, a delayed press release not yet indexed by major news aggregators, insider trading activity ahead of an unannounced event, or purely technical chart-driven buying. Given the stock's modest price and position as the fifth-largest gainer of the day, this appears more consistent with speculative or technical factors than fundamental catalysts. Without access to company press releases, SEC filings, or real-time trading volume data, the true driver remains opaque.

PHGE

BiomX Inc.Industrials

$1.62+$0.80

+98.4%

AMEX · Mkt cap $1.5 M

No news headlines were available in the last 48 hours to explain the 98% surge, so the driver remains unknown; this jump is typical of micro-cap biotech stocks that can move sharply on rumors, technical factors, or delayed announcements.

The absence of any recent news headlines is notable given the magnitude of the move. BiomX is a micro-cap biotech company trading on the AMEX, a category of stock known for high volatility and sensitivity to non-headline catalysts. A near-doubling in price could reflect several plausible but unconfirmed mechanisms: a clinical trial result or regulatory update that has not yet appeared in the RSS feed, short covering or retail momentum following a technical breakout, insider activity or rumors circulating on micro-cap trading forums, or a delayed market reaction to a development announced before the 48-hour window. Without corroborating news, the specific cause cannot be isolated from these possibilities.

CPSH

CPS Technologies CorporationTechnology

$11.12+$5.12

+85.3%

NASDAQ · Mkt cap $77 M

CPS Technologies surged 85% on May 26, 2026, but no news headlines were published in the prior 48 hours, making the specific catalyst unknown. The move likely reflects delayed news dissemination, technical factors, or undisclosed company developments.

No recent news headlines appear in the Yahoo Finance RSS feed for the 48-hour window preceding this snapshot, which is unusual for an 85% intraday gain ranking in the top 10 movers. This disconnect suggests several possibilities. First, the catalyst may have been announced but not yet aggregated into the headline feed at the time of data collection. Second, CPS Technologies may have issued a press release or filed an SEC document (such as an 8-K or earnings report) that has not yet propagated to major financial news aggregators. Third, the move could reflect technical factors such as short covering, options expiration dynamics, or algorithmic trading response to volume spikes. CPS is a specialty materials manufacturer historically subject to cyclical demand and contract-specific catalysts. Without documented headlines, attribution remains speculative, and investors should verify the actual cause through SEC filings or direct company communications.

PCLA

PicoCELA Inc.Communication Services

$12.00+$5.38

+81.3%

NASDAQ · Mkt cap $62 M

No headlines were found in the last 48 hours, so the cause of the 81.27% jump cannot be identified from available news. The move likely reflects a significant corporate event, technical catalyst, or market rumor not yet captured in the provided news feed.

The absence of any headlines in the last 48 hours makes it impossible to pinpoint a specific news driver for PCLA's dramatic 81.27% gain. An eighty percent move is typically triggered by material events such as FDA approvals or rejections for biotech firms, acquisition announcements, clinical trial results, earnings surprises, or major contract awards. Given that PicoCELA appears to be a specialized life sciences or biotech company based on its name, possible unstated catalysts could include positive clinical data, a partnership announcement, or regulatory milestone. Alternatively, the move could reflect a delayed market reaction to news released just outside the 48-hour window, or a technical event such as a short squeeze if the stock had significant short interest. Without corroborating headlines, all such explanations remain speculative.

CODX

Co-Diagnostics, Inc.Healthcare

$9.11+$4.04

+79.7%

NASDAQ · Mkt cap $6.9 M

Co-Diagnostics announced expansion of its Ebola PCR test development efforts through a joint venture with CoSara, sparking a nearly 80% single-day surge as part of a broader 630% rally over six trading sessions.

The company disclosed advancement of its development strategy for a PCR assay targeting the Bundibugyo strain of Ebola virus, formalized through a joint venture arrangement with CoSara. This announcement appears to have catalyzed renewed investor interest in the molecular diagnostics platform. The headline noting the stock has surged over 630% in just six sessions suggests this represents continuation of an existing momentum move rather than an isolated catalyst. Retail traders are reportedly betting the rally will continue. The scale of the single-day gain relative to the company's market capitalization and historical volatility indicates either strong conviction around the Ebola diagnostic opportunity, technical factors amplifying moves in a thinly-traded name, or both. Without visibility into trading volume, short interest, or recent price history prior to the six-session rally, the full driver mix remains partially opaque.

BRAI

Braiin LtdTechnology

$12.49+$5.32

+74.2%

NASDAQ · Mkt cap $1.1 B

Braiin announced a strategic partnership with Switchcraft to embed utility and telecom switching capabilities into its UK platform, targeting an estimated £25 billion market opportunity, driving a 74% gain on the day.

The headlines establish a concrete partnership announcement between Braiin and Switchcraft focused on integrating white-labelled switching infrastructure for electricity, gas, broadband, and telecom services into Braiin's AI-native Living Infrastructure platform targeting the UK residential lifecycle services market. One headline references a "$33B opportunity" and notes the stock reached a 159% intraday peak before settling at the reported +74% close. The partnership appears to materially expand Braiin's addressable market and service capabilities in a large UK market segment. This is a standard positive corporate development announcement: new partnership, expanded addressable market, and integration of complementary infrastructure services. No earnings surprise, regulatory action, or other catalyst is mentioned, so the move appears directly attributable to investor enthusiasm over the partnership's strategic value and market size.

UZX

Linkage Global Inc. Class A Ordinary SharesConsumer Cyclical

$0.77+$0.32

+72.7%

NASDAQ · Mkt cap $7.8 M

Linkage Global announced an $8 million share repurchase program on the same day it completed a Nasdaq ticker change to UZX, signaling management confidence and likely driving the 72.65% intraday surge.

The headline directly ties the share repurchase announcement to the recent ticker change to UZX on Nasdaq. A $8 million buyback program is a concrete capital allocation signal that typically reflects management's belief that shares are undervalued, which can attract short-covering, retail interest in a newly listed or renamed ticker, and general positive sentiment. The confluence of two corporate actions—the fresh ticker identity and the repurchase—on the same trading day likely amplified attention and buying pressure. The stock's rank as the 11th biggest gainer suggests broad momentum participation. However, the headline excerpt is truncated and does not provide context on the company's sector, prior trading range, or whether the repurchase size is material relative to market cap, all of which would help validate the magnitude of the move.

MWC

Micware Co., Ltd. American Depositary SharesConsumer Cyclical

$7.70+$2.42

+45.8%

NASDAQ · Mkt cap $88 M

No news headlines were available in the last 48 hours to explain MWC's 45.83% jump, making the specific catalyst unknown without additional reporting.

The absence of any news in the Yahoo Finance RSS feed over the last two days is notable given the stock's significant 45.83% intraday gain and ranking as the 12th biggest gainer. Without identifiable headlines, the move likely stems from one of several categories: a delayed market reaction to earlier company announcements not captured in the 48-hour window, technical factors such as short covering or options-related momentum, broader sector rotation, retail trading activity around a particular catalyst the market is aware of but financial news services have not yet prominently indexed, or an announcement made through alternative channels not yet reflected in mainstream financial news feeds. For a lower-cap ADR like MWC, thinly traded securities can also experience outsized moves on relatively modest volume shifts.

FUTG

Leverage Shares 2x Long FUTU Daily ETF

$4.43+$1.35

+43.8%

ARTL

Artelo Biosciences, Inc.Healthcare

$1.71+$0.52

+43.7%

NASDAQ · Mkt cap $3.3 M

No news headlines were available in the last 48 hours, so the cause of the 43.70% jump cannot be determined from public announcements. The move likely reflects technical or sentiment-driven trading in a micro-cap biotech stock.

Artelo Biosciences is a small-cap biotech company with a market presence primarily in cannabinoid-based therapeutics. The absence of any news in the Yahoo Finance RSS feed over the last 48 hours means the jump cannot be attributed to earnings, FDA actions, partnerships, or guidance updates. For micro-cap biotech stocks trading near $1.71, significant single-day moves often stem from technical factors such as short covering, algorithmic repositioning, retail sentiment shifts, or delayed coverage of prior announcements. Alternatively, the catalyst could be a press release or clinical development news that has not yet propagated to major financial news aggregators. Without access to the company's investor relations directly or trading volume context, attribution remains speculative.

MULL

GraniteShares 2x Long MU Daily ETF

$648.75+$181.66

+38.9%

NASDAQ

No news headlines were found in the last 48 hours, but MULL is a 2x leveraged long ETF on Micron Technology, so a ~19% surge in the underlying MU stock would mechanically produce a ~38% gain in this security.

The absence of news headlines for MULL itself is consistent with this being a passive leveraged ETF that tracks Micron Technology daily performance with 2x leverage. A single-day move of +38.89% in a 2x long daily ETF typically reflects a substantial move in the underlying MU stock rather than ETF-specific news. This kind of daily amplification is the designed behavior of leveraged instruments. Without access to MU's own news or price action on May 25–26, 2026, the most probable cause is either a significant positive development for Micron (earnings beat, guidance raise, semiconductor tailwinds, or M&A speculation) or broad-based sector strength in semiconductor stocks. Technical catalysts like short covering in MU could also drive a sharp single-day move in the underlying that would be magnified 2x in this ETF.

MUU

Direxion Daily MU Bull 2X ETF

$740.00+$205.63

+38.5%

NASDAQ

No news headlines were found in the last 48 hours, but MUU is a 2X leveraged ETF tracking Micron Technology (MU), so a strong rally in MU stock would amplify into roughly double that move in the fund.

Zero news headlines appeared in the search results for the past two days, so there is no direct evidence of a specific corporate announcement or market event tied to MUU itself. However, MUU is structured as a daily leveraged bull ETF with 2X exposure to Micron Technology (MU). A +38.48% one-day gain in MUU strongly suggests an unusually large single-day move in the underlying MU stock, likely somewhere in the range of +15% to +20% depending on daily rebalancing effects. The most probable drivers of such a move in semiconductor equities typically include earnings beats, positive industry commentary, activist involvement, a major product announcement, or a broad positive shift in semiconductor sector sentiment. Without access to the actual MU price movement or news, the move cannot be attributed to a specific catalyst.

DTSQR

DT Cloud Star Acquisition Corporation

$0.15+$0.04

+35.5%

NASDAQ

No news headlines were found in the last 48 hours, so the 35% gain cannot be directly attributed to a specific disclosed event. The move likely reflects either technical trading, delayed news pickup, or speculation typical of blank-check acquisition vehicles.

DT Cloud Star Acquisition Corporation is a SPAC, a category of security prone to volatile intraday swings driven by merger rumors, technical reversals, or coordinated retail interest rather than fundamental corporate news. The complete absence of recent headlines despite a top-20 daily gain suggests the catalyst was either not yet picked up by major news feeds, occurred via social media or specialized trading forums, or was purely technical in nature—such as a short squeeze, options-related gamma effects, or algorithmic accumulation at support levels. SPACs trading near cash value (this stock at $0.15 is well below typical redemption levels) can gap sharply on thin volume when sentiment shifts, even without material news.

NRXP

NRx Pharmaceuticals, Inc.Healthcare

$4.31+$1.09

+33.9%

NASDAQ · Mkt cap $147 M

No news headlines were found in the last 48 hours, so the 33.85% gain on May 26 likely reflects a delayed market reaction to an earlier announcement, a technical/short-squeeze move, or undisclosed company news not yet picked up by major news feeds.

NRx Pharmaceuticals showed a strong single-day gain of 33.85%, ranking as the 18th biggest gainer on the day, yet no corresponding news appeared in the Yahoo Finance RSS feed within the last 48 hours. This disconnect suggests several possible explanations. First, the catalyst could be a news event from more than 48 hours prior that the market is only now digesting or that triggered a delayed options expiration or rebalancing effect. Second, for a smaller-cap biopharmaceutical company, a material announcement such as positive clinical trial data, a partnership, regulatory progress, or financing news could have been released through other channels (the company's investor relations site, a press release service) before reaching broad news aggregators. Third, given the magnitude of the move, a short squeeze or technical breakout cannot be ruled out. Without access to recent company filings or press releases beyond the news feed provided, attribution remains speculative.

ECOR

electroCore, Inc.Healthcare

$8.91+$2.24

+33.6%

NASDAQ · Mkt cap $97 M

No news headlines were found in the last 48 hours, so the 33.58% jump likely stems from a delayed announcement, technical catalyst, or market rumor that has not yet been captured in the available news feed.

ElectroCore is a biomedical device company focused on non-invasive vagus nerve stimulation therapies. A gain of this magnitude in a single day without corresponding news coverage in the immediate window is unusual and warrants investigation into several plausible categories: potential FDA clearance or approval announcement for a key product, positive clinical trial results, strategic partnership or licensing deal, analyst upgrade, short covering, or broader sector rotation into neuromodulation stocks. Given the absence of headline data, it is also possible that news broke very recently (within hours) and has not yet propagated through the RSS feed, or that the catalyst is a delayed market reaction to information released earlier. For a smaller-cap medical device company, investor sentiment can shift sharply on regulatory or clinical milestones. Without the specific news, any single explanation remains inference rather than fact.

SNGX

Soligenix, Inc.Healthcare

$0.51+$0.12

+31.5%

NASDAQ · Mkt cap $8.3 M

Soligenix announced its vaccine platform may be suitable for treating Bundibugyo virus, linked to recent Ebola outbreak in Congo, likely sparking investor optimism about a potential new therapeutic application and market opportunity.

On 2026-05-26, Soligenix released a statement noting the suitability of its vaccine platform for Bundibugyo virus, an Ebola-related pathogen tied to an active outbreak in Congo. For a late-stage biopharmaceutical company focused on rare diseases, news of a potential application to an emerging infectious disease with clear unmet medical need and possible regulatory urgency could plausibly drive a 31.5% single-day gain. The announcement appears to position the company's existing platform as a candidate solution to an immediate public health crisis, which may have attracted both biotech investors and short-covering activity. The headline is truncated and does not provide full detail on whether this is exploratory, preclinical, or further along, so the exact scope of the development opportunity remains unclear from the available text.

WCT

Wellchange Holdings Company LimitedTechnology

$2.15+$0.51

+31.1%

NASDAQ · Mkt cap $4.1 M

No news headlines were found in the last 48 hours, so the 31% gain on May 26 likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or undisclosed company news not yet indexed by Yahoo Finance.

The absence of any news coverage in the last 48 hours makes it impossible to identify a specific catalyst for WCT's sharp 31% single-day rally. This rank as the 21st biggest gainer suggests material volume and interest. For a smaller-cap or lower-priced stock like WCT trading at $2.15, moves of this magnitude can be triggered by several mechanisms: delayed reactions to earnings or guidance released outside the headline window, short covering or technical breakouts, insider activity, unconfirmed rumors circulating on retail trading forums, or a press release that has not yet been picked up by major news aggregators. Without corroborating headlines, any specific explanation remains speculative. The lack of indexed news within 48 hours is itself notable and suggests either the catalyst occurred earlier or has not yet reached mainstream financial media.

ATOM

Atomera IncorporatedTechnology

$12.11+$2.87

+31.1%

NASDAQ · Mkt cap $212 M

No relevant news headlines were found in the last 48 hours, so the 31% gain cannot be directly attributed to a specific announcement. The move likely reflects either a delayed reaction to an earlier event, technical buying, or market sentiment shift specific to the semiconductor or materials scie…

Atomera is a materials science company focused on advanced semiconductor technology, and a 31% single-day jump in the absence of same-day or prior-day news headlines suggests the catalyst occurred outside the provided information window or is non-news-driven. Possible explanations within the semiconductor space include a favorable analyst upgrade or research development that circulated before formal press release, short covering if the stock had recent downward pressure, or market-wide positive sentiment toward semiconductor materials suppliers. Without access to intraday trading patterns, institutional positioning, or news from sources outside the Yahoo Finance RSS feed provided, we cannot pinpoint the specific trigger. The lack of headline support means either the news has not yet been formally published, was released through a channel not captured in this snapshot, or the move reflects technical factors rather than fundamental disclosure.

NCPL

Netcapital Inc.Financial Services

$1.07+$0.25

+30.6%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours for NCPL, so the 30.65% gain cannot be attributed to a specific disclosed event. The move likely reflects technical trading, options activity, or undisclosed market developments.

The absence of recent news headlines is notable given the magnitude of the single-day gain, which ranks NCPL at number 23 among all gainers. This suggests the catalyst was either not yet widely reported through major financial news feeds, or the move was driven by non-news factors. Netcapital is a fintech platform focused on crowdfunding and investment opportunities for accredited and non-accredited investors. Stocks in this category can experience sharp moves from technical factors such as short covering, options gamma effects on low-float securities, or algorithmic trading responses to price thresholds. Without disclosed company news, earnings, guidance changes, or regulatory actions to point to, the move remains unexplained by the information provided here.

AREB

American Rebel Holdings, Inc.Consumer Cyclical

$0.06+$0.01

+30.6%

NASDAQ · Mkt cap $4.8 M

A headline about Champion Safe and West Coast Safes' strong sales and inventory push at the LA County Fair was published on the snapshot date, but this appears to be a general marketing announcement rather than company-specific news that would justify a 30% single-day jump for AREB.

The only headline provided is a promotional press release about Champion Safe and West Coast Safes activity at the LA County Fair, dated May 26, 2026. While this suggests promotional momentum, it does not contain material business developments (earnings, guidance, contract wins, or regulatory approvals) that typically drive 30% moves in penny stocks. AREB trades at $0.06 and ranks as the 24th biggest gainer, indicating broad trading activity. Without additional news, the move likely reflects either a delayed market reaction to prior announcements, technical factors common in low-priced equities (thin float, short covering, retail interest), or information not captured in the provided headlines. Micro-cap stocks are particularly prone to outsized percentage moves on modest volume.

KORU

Direxion Daily MSCI South Korea Bull 3X ETF

$1,014.98+$234.63

+30.1%

AMEX

KORU, a 3x leveraged South Korea ETF, surged 30% on May 26 likely due to a sharp rally in the underlying MSCI South Korea index, amplified by the fund's 3x daily reset mechanism.

The only substantive headline provided discusses KORU's extreme YTD gains (274%) and 12-month returns (1,500%), but does not identify a specific catalyst for today's 30% move. However, KORU's structure is critical context: it is a daily reset leveraged ETF that amplifies moves in the MSCI South Korea index threefold each day. A typical day of strength in South Korean equities would translate to roughly 3% underlying movement becoming 9% in the fund; a 30% move suggests either an exceptional rally in the underlying index, significant intraday volatility that compounded favorably, or a combination of both. No news headline attributes the move to a specific economic announcement, corporate earnings, policy change, or geopolitical event. The move is most likely explained by strong daily performance in South Korean equities, mechanically amplified by KORU's leverage structure.

JBDI

JBDI Holdings LimitedConsumer Cyclical

$0.55+$0.13

+30.0%

NASDAQ · Mkt cap $12 M

No news headlines were available in the last 48 hours to explain JBDI's 30% gain, so the catalyst remains unclear; the move likely reflects either delayed announcements, technical trading, or retail interest in this low-priced stock.

Yahoo Finance returned no headlines in the past 48 hours for JBDI Holdings Limited despite a significant 30% single-day rally that ranked it 26th among all daily gainers. This absence of contemporaneous news coverage is notable and limits our ability to identify a specific catalyst. Low-priced stocks under $1 are often subject to technical rebounds after prior declines, short-covering, or amplified retail trading activity that may lack fundamental justification. Alternatively, the catalyst may be a delayed announcement not yet indexed by news aggregators, an earnings report, a partnership, or guidance update released outside the 48-hour window. Without access to the company's own disclosures or to news sources beyond Yahoo Finance, we cannot determine whether this move reflects genuine company developments or primarily technical and sentiment-driven trading in a security that typically experiences high volatility.

NAMI

Jinxin Technology Holding Company American Depositary SharesCommunication Services

$0.39+$0.09

+29.9%

NASDAQ · Mkt cap $9.0 M

No news headlines were found in the last 48 hours, so the 29.87% gain cannot be directly attributed to a specific announced event. The move may reflect technical trading, delayed market reaction to older news, or speculation in a low-priced stock.

NAMI closed at $0.39, up nearly 30% on the day, but Yahoo Finance returned no relevant news headlines within the past 48 hours. This absence of contemporary news is significant and means the price action cannot be tied to a corporate announcement, earnings report, regulatory decision, or partnership deal disclosed recently. For penny stocks and micro-cap securities like NAMI, sharp single-day moves often occur due to technical factors such as covering of short positions, algorithmic trading activity triggered by volume thresholds, or retail investor interest driven by social media rather than fundamental company news. It is also possible that meaningful news was disseminated through channels not indexed by Yahoo Finance RSS, or that the market is reacting to delayed information from prior days that has only now gained traction. Without access to those alternative news sources or internal company announcements, the specific catalyst remains unclear.

AGPU

Axe Compute Inc.Technology

$6.92+$1.58

+29.6%

T1 Energy IncIndustrials

$10.45+$2.37

+29.3%

NYSE · Mkt cap $1.3 B

T1 Energy surged 29% on May 26 following an analyst upgrade and bullish sentiment, despite concurrent short-seller allegations, as reported in the May 25 headline highlighting the stock as one of the day's top gainers.

The single headline provided references a 42.5% weekly surge driven by optimistic analyst ratings and what appears to be value-based buying, with the stock described as offering bargain pricing despite short-seller claims. The May 26 intraday move of 29% aligns with continued momentum from this analyst-driven rally. However, the headline is incomplete—it does not specify the analyst firm, the rating change itself, target price, or the nature of the short-seller allegations. The article excerpt cuts off mid-sentence and does not clarify whether the analyst upgrade occurred on May 25 or earlier in the week. Without the full text, we cannot rule out that additional catalysts (operational updates, contract wins, or sector rotation) contributed to the move. The evidence suggests analyst sentiment as the primary driver, but the incomplete headline limits confidence in the specifics.

OTLK

Outlook Therapeutics, Inc.Healthcare

$0.40+$0.09

+29.1%

NASDAQ · Mkt cap $167 M

Outlook Therapeutics surged 29% after winning an FDA appeal for its eye disease drug Lytenava and planning to resubmit its biologics license application in June 2026, removing a major regulatory obstacle.

The headlines establish a concrete regulatory catalyst: the FDA granted Outlook's appeal in a formal dispute resolution process concerning its bevacizumab-vikg (Lytenava) candidate for eye disease. This appeal win clears the path for a June 2026 BLA resubmission, which represents significant progress for a clinical-stage biopharmaceutical company that had previously faced FDA rejection. For small-cap biotech stocks, FDA approval decisions and appeal outcomes are primary drivers of valuation because they determine whether a pipeline asset can reach commercialization. The 29% single-day move is proportionate to this type of binary regulatory win. One headline notes pre-market gains exceeded 50%, suggesting the market may have initially overshot before settling back somewhat, though the close still reflects substantial enthusiasm about the resubmission pathway.

SDA

SunCar Technology Group Inc.Consumer Cyclical

$0.68+$0.15

+28.6%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours, so the 28.59% gain cannot be attributed to a specific announced event; the move likely reflects technical trading, short covering, or unindexed market sentiment on a low-priced stock.

SunCar Technology Group Inc. is a micro-cap stock trading at $0.68, and the absence of any news in the Yahoo Finance RSS feed over the past 48 hours means the price jump cannot be grounded in a disclosed earnings report, regulatory action, partnership announcement, or guidance change. Low-priced stocks in the sub-dollar range are often subject to amplified volatility from technical factors such as short squeezes, options expiration effects, or algorithmic trading. Alternatively, the gain could reflect positive sentiment from a press release, investor presentation, or social media discussion that has not yet been indexed by mainstream financial news sources, or a delayed market reaction to news released just before the 48-hour window. Without substantive information about the company's fundamentals or recent catalysts, the specific cause remains opaque.

LICN

Lichen International LimitedIndustrials

$1.08+$0.24

+28.5%

NASDAQ · Mkt cap $21 M

No news headlines are available in the last 48 hours for LICN, so the 28.51% gain cannot be directly attributed to a disclosed catalyst. The jump likely reflects technical factors, delayed news flow, or market speculation in a thinly-traded microcap.

The absence of recent news coverage for a stock experiencing a nearly 29% single-day gain is significant and suggests the move was not driven by a major announced event like earnings, regulatory approval, merger activity, or guidance revision. Microcap stocks trading on NASDAQ at these price levels are often subject to technical momentum, short covering, low-volume amplification of modest buying, or retail attention from social media or trading forums. Without visibility into volume patterns, short interest, or intraday order flow, it is difficult to distinguish between genuine fundamental news that simply has not yet propagated to major news aggregators and technical factors driving price appreciation. The timing gap between the price action and news availability means a material announcement may have occurred but not yet been indexed by the RSS feed used here.

LAFAR

LaFayette Acquisition Corp. Rights

$0.14+$0.03

+27.3%

NASDAQ

No news headlines were found in the last 48 hours, so the 27% jump in LAFAR rights on May 26 likely reflects either a technical bounce in a thinly traded security, delayed market reaction to an earlier announcement, or retail interest in the underlying SPAC merger.

LaFayette Acquisition Corp. Rights are a SPAC-related security, which means their value depends heavily on the merger timeline and deal terms of the parent SPAC entity. Because no recent headlines appear in the search results, the price jump is not directly attributable to breaking news. However, SPAC rights are inherently volatile and trade in low volumes, so modest price moves can appear as large percentage gains. The 27% move could reflect renewed retail or institutional interest ahead of a shareholder vote, a leaked development in merger negotiations, or simply technical momentum in a thinly traded instrument. Without confirmation of a specific catalyst, any explanation remains speculative. It is also possible that a relevant announcement was made but did not appear in the Yahoo Finance RSS feed used here.

NXL

Nexalin Technology, Inc.Healthcare

$0.48+$0.10

+27.1%

NASDAQ · Mkt cap $7.3 M

No news headlines were found in the last 48 hours, so the 27% gain on NXL likely reflects technical trading, retail attention, or an untracked announcement rather than a documented corporate event.

Nexalin Technology is a micro-cap biomedical device company, and the absence of news in Yahoo Finance's RSS feed does not guarantee no event occurred—press releases may be delayed in aggregation, or the move may stem from social media attention, short covering, or technical momentum in a thinly traded stock. Micro-cap stocks with small floats are prone to outsized moves on modest volume. The company's core business involves neuromodulation devices for psychiatric and neurological conditions, a space that can attract speculative interest if clinical or regulatory milestones are announced through channels not immediately captured by mainstream financial media. Without corroborating headlines or structural insight into known catalysts, the driver remains speculative.

BIYA

Baiya International Group Inc. Ordinary SharesTechnology

$1.65+$0.35

+26.9%

NASDAQ · Mkt cap $71 M

No news headlines were found in the last 48 hours, so the 26.92% gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, retail interest, or undisclosed material information.

The absence of any news headlines in the Yahoo Finance RSS feed over the past 48 hours makes it impossible to identify a concrete catalyst for BIYA's 26.92% single-day jump. The stock remains thinly traded and relatively obscure, which means price movements can be amplified by small volumes or coordinated trading activity. Possible explanations include a technical bounce off support levels, short covering if the stock has a notable short float, renewed retail interest perhaps driven by social media or message boards rather than formal press releases, or a delayed market response to company developments that were announced but not yet widely indexed in major news feeds. Without additional context about BIYA's sector, financial condition, or recent corporate actions, the underlying driver remains speculative.

MTEX

Mannatech, IncorporatedConsumer Defensive

$5.53+$1.16

+26.5%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 26.54% surge in MTEX stock cannot be attributed to a specific announced event; the move likely reflects technical trading, short-covering, or delayed market reaction to an earlier development.

MTEX jumped 26.54% to rank 36th among daily gainers, yet zero headlines appear in the search results for the prior 48 hours. This absence of reported catalysts makes it difficult to pinpoint a definitive cause. For a smaller-cap nutrition and wellness company like Mannatech, such moves typically stem from one of several categories: technical rebounds after oversold conditions, short squeeze activity given potential float constraints, delayed market pricing of older announcements, insider activity, or non-headline-tracked corporate developments like conference presentations, partnership discussions, or restructuring steps. Without corroborating news, any explanation remains speculative. The timing and magnitude suggest something more than random drift, but identifying whether it was fundamental or technical requires additional information not available in the provided sources.

RIBBR

Ribbon Acquisition Corp Rights

$0.25+$0.05

+26.3%

NASDAQ · Mkt cap $1.2 M

No news headlines were found in the last 48 hours, but the 26% gain in a SPAC rights offering suggests either technical buying, warrant/redemption dynamics, or a delayed announcement not yet reflected in the news feed.

Ribbon Acquisition Corp Rights (RIBBR) rose 26% with zero news coverage in the past two days according to the available feed. This is a rights offering tied to a SPAC structure, which means the price action is driven by different mechanics than common equity. SPAC rights often experience sharp moves based on (1) changes in redemption activity or shareholder vote expectations around the underlying merger, (2) technical factors tied to ex-dates or warrant conversions, or (3) material news about the merger target that hasn't yet propagated to the headline aggregator. Without confirmed news, the jump is difficult to attribute definitively, but SPAC rights are prone to volatility on procedural or structural shifts rather than fundamental company announcements.

CXAI

CXApp Inc.Technology

$0.23+$0.05

+25.2%

NASDAQ · Mkt cap $10 M

No news headlines were available in the last 48 hours, so the 25% gain cannot be directly attributed to a disclosed event. The move likely reflects either technical buying, delayed news dissemination, or market-driven speculation in a micro-cap stock.

CXApp Inc. is trading at $0.23 and gained 25% to rank 38th among daily gainers, yet no recent news appeared in the Yahoo Finance RSS feed over the last two days. This disconnect is common in micro-cap and penny stocks, where price movements can be driven by several factors independent of major news: thin liquidity amplifying small orders, technical chart breakouts, social media attention, delayed or regional news not yet indexed by major feeds, insider activity, or simple momentum trading. Without a specific catalyst identified in available headlines, the move cannot be tied to earnings, guidance, partnerships, or regulatory events. The absence of news coverage itself suggests this is unlikely a major corporate action, making speculative or technical factors the most probable explanations.

APACR

StoneBridge Acquisition II Corporation Rights

$0.15+$0.03

+25.0%

RFAMR

RF Acquisition Corp III Rights

$0.15+$0.03

+25.0%

NASDAQ

No news headlines were found in the last 48 hours for RFAMR, so the 25% gain most likely reflects either technical trading activity, options-related moves, or a delayed market reaction to an untracked corporate event typical of SPAC-related instruments.

RFAMR is a rights offering vehicle associated with a SPAC (special purpose acquisition company), a security class that can experience outsized percentage moves on relatively low dollar volume due to thin trading and high leverage in retail portfolios. The absence of any news in the Yahoo Finance feed does not rule out internal corporate activity such as announcements on merger timelines, shareholder votes, or deal clarity that may not yet have propagated through major news channels. Rights offerings are particularly sensitive to changes in sentiment around the underlying acquisition target or SPAC sponsor actions. Alternatively, the move could reflect technical factors such as short covering, algorithmic rebalancing, or options expiration activity. Without headline evidence, the specific catalyst remains unknown.

ASPI

ASP Isotopes Inc. Common StockBasic Materials

$6.93+$1.38

+24.9%

NASDAQ · Mkt cap $603 M

ASP Isotopes announced successful restart of its Silicon-28 enrichment facility with first 18 stages operational and commercial shipments expected in Q3 2026, validating its strategy after implementing facility modifications and signing three customer contracts.

The 24.86% jump is directly tied to ASP Isotopes' operational milestone announcement on May 26. The company confirmed it has successfully restarted the first 18 stages of its Silicon-28 enrichment facility following engineering enhancements to non-core infrastructure components implemented over the prior six months. This is material because the company previously announced three signed commercial contracts for enriched Silicon-28 supply to U.S. customers and is now providing concrete validation that it can deliver on those commitments in Q3 2026. The timing of the restart news coincides with the release of Q1 2026 results showing revenue growth to $4.18 million and narrowing net losses, suggesting operational momentum. Investors appear to be rewarding the transition from development stage to commercialization phase with demonstrated facility readiness.

SKIN

The Beauty Health CompanyHealthcare

$0.86+$0.17

+24.8%

NASDAQ · Mkt cap $98 M

No news headlines were found in the last 48 hours, so the 24.81% gain on SKIN likely reflects a technical rebound, short covering, or delayed market reaction to an earlier announcement not captured in the RSS feed.

The Beauty Health Company (SKIN) jumped 24.81% to $0.86 with no corresponding news in the last 48 hours according to the provided RSS data. This disconnect suggests either that relevant news exists but was not indexed by Yahoo Finance RSS, or that the move is driven by technical factors. For a micro-cap or distressed stock trading near $1, common catalysts include short squeeze activity, options expiration mechanics, delayed earnings results, regulatory updates, or analyst coverage changes. The stock's extremely low price and placement in the top 42 gainers suggest retail interest or a reversion trade. Without substantive headlines, the cause remains speculative.

STFS

Star Fashion Culture Holdings LimitedCommunication Services

$9.32+$1.82

+24.3%

NASDAQ · Mkt cap $5.3 M

No news headlines were found in the last 48 hours for STFS, so the 24.27% gain lacks a confirmed catalyst from public disclosures; the jump may reflect technical trading, delayed news digestion, or unattributed developments.

The absence of recent news in the Yahoo Finance RSS feed makes it impossible to identify a specific event driving STFS's strong gain today. Star Fashion Culture is a small-cap apparel company, and moves of this magnitude in that sector can reflect several patterns: short covering if the stock had elevated short interest, technical breakouts from chart-based trading or options mechanics, market-wide momentum shifts in fashion or consumer discretionary names, or delayed market reaction to older news. Without headline evidence, we cannot rule out private information circulating among traders, a corporate announcement released through channels other than the Yahoo RSS, or pure momentum-driven trading in a thinly traded name.

VICR

Vicor CorporationTechnology

$332.95+$64.96

+24.2%

ALP

AlphaTON Capital Corp. Common StockFinancial Services

$0.45+$0.09

+24.1%

NASDAQ · Mkt cap $4.1 M

AlphaTON announced a $21 million next-twelve-months sales outlook and highlighted a $32.2 million AI lab contract, validating its pivot to revenue-generating AI compute services and signaling meaningful scale-up potential.

The headline from May 26 reveals that Alpha Compute Corp. (ALP) has published a quarterly update showcasing a concrete pivot toward AI compute services with identifiable revenue traction. The announcement centers on two specific data points: a $32.2 million AI lab contract that appears to be already secured or substantially validated, and a forward-looking $21 million NTM sales guidance. For a micro-cap stock trading at $0.45, this kind of visibility into near-term revenue generation from a strategically important sector (AI compute) represents a material positive catalyst. The framing as a "scale-up potential" highlights demonstrates management confidence in growth trajectory. The 24% single-day gain is consistent with investors repricing a formerly speculative story into one with tangible contract wins and revenue guidance.

ATON

AlphaTON Capital Corp.Healthcare

$0.45+$0.09

+24.0%

NASDAQ · Mkt cap $667 K

No news headlines appeared in the last 48 hours for ATON, so the 24% gain likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or untracked catalysts such as insider developments or sector-wide momentum.

AlphaTON Capital Corp. shows a significant single-day gain of 24% while ranking among the top 50 gainers on NASDAQ, yet no recent news appears in major financial feeds within the 48-hour window. This disconnect suggests several possibilities. First, the catalyst may have occurred earlier than the 48-hour cutoff and the market is only now repricing the stock. Second, ATON, a blank check or special purpose acquisition company, could be reacting to merger rumors, shareholder votes, or trust liquidation announcements that circulate through less-tracked channels. Third, the move could reflect technical momentum, short covering, or retail trader interest rather than fundamental news. Without headline evidence, the specific driver remains opaque, though SPAC-related catalysts (merger announcements, PIPE confirmations, or redemption-rate guidance) have historically driven outsized single-day moves in this category of stock.

SMTK

SmartKem, Inc.Technology

$0.30+$0.06

+24.0%

NASDAQ · Mkt cap $2.2 M

No news headlines were found in the last 48 hours to explain SmartKem's 24% single-day jump; the move likely reflects technical trading, delayed news dissemination, or undisclosed company developments.

SmartKem is a micro-cap semiconductor materials company trading at $0.30, which is the price range where stocks become extremely sensitive to small absolute dollar moves and low volume can amplify percentage swings. The absence of any news in the Yahoo Finance RSS feed in the preceding 48 hours means the headline-driven catalyst model does not apply here. For a stock of this market cap and liquidity profile, possible drivers of a 24% move include: first, a technical bounce off support after a prior decline, which can accelerate sharply in thin trading; second, a delayed or embargoed press release that hit wires outside the 48-hour window captured; third, social media or message board accumulation driving retail interest; or fourth, reaction to developments at peer companies in the materials space. Without access to real-time order flow, company filings, or extended news archives, the specific cause remains unknown.

LFVN

LifeVantage CorporationConsumer Defensive

$6.93+$1.32

+23.5%

NASDAQ · Mkt cap $83 M

No news headlines were found in the last 48 hours, so the 23.53% gain cannot be directly attributed to a reported catalyst. The move may reflect technical trading, delayed news pickup, or unconfirmed market rumors.

LifeVantage is a nutritional supplement and wellness company whose stock often exhibits volatility in response to earnings reports, product announcements, or shifts in direct-sales-model sentiment. With no headlines captured in the RSS feed during the past 48 hours, the jump is not traceable to a named corporate event, regulatory approval, or guidance revision. Possible explanations for such a move in a small-cap wellness stock include short covering or technical oversold conditions, an earnings announcement or insider news not yet indexed by Yahoo Finance, or a broader sector rotation into health and supplement companies. Without confirmed news, any explanation remains speculative.

HTT

High Templar Tech LimitedFinancial Services

$3.01+$0.57

+23.4%

NYSE · Mkt cap $388 M

High Templar Tech announced a modified Dutch auction tender offer to repurchase up to 39 million ADSs on May 26, likely triggering the 23.36% gain as the market rewarded the shareholder-friendly capital allocation signal.

The most relevant headline is the formal announcement on 2026-05-26 at 10:30:00 UTC that High Templar Tech commenced a tender offer to repurchase up to 39 million of its American Depositary Shares using a modified Dutch auction process. Tender offers and share buybacks are typically viewed positively by markets because they signal management confidence in valuation, reduce share count (benefiting earnings per share for remaining shareholders), and represent a return of capital to shareholders. The timing on May 26 morning aligns precisely with the trading day's gain. The other headlines reference broad market uptrends and general "undiscovered gems" commentary unrelated to HTT specifically. No earnings beat, acquisition, or operational catalyst was disclosed in the provided news, so the tender offer announcement stands as the only company-specific event that would plausibly drive a 23% single-day rally.

NCRA

Nocera, Inc.Consumer Defensive

$0.30+$0.06

+22.8%

NASDAQ · Mkt cap $3.2 M

No headlines were found in the last 48 hours, so the 22.76% gain cannot be attributed to publicly reported news. The move likely stems from technical trading, low liquidity amplification, or undisclosed market rumors.

Nocera is a penny stock trading at $0.30, which makes it highly susceptible to volatile price swings driven by factors other than fundamental news. The absence of any headlines in the Yahoo Finance RSS feed over the past two days means we cannot point to an earnings surprise, product announcement, financing event, or regulatory development as the cause. For stocks in this price range, such jumps often reflect technical bounces off support levels, short covering in a thinly traded name, retail buying interest, or unverified claims circulating on social media or message boards. Without access to intraday volume data, options activity, or insider filings, we cannot distinguish between these possibilities. The ranking as the 50th biggest gainer suggests the move was real but provides no insight into its cause.

Biggest Losers

Tue, May 26, 2026 50

ADTX

Aditxt, Inc.Healthcare

$0.25−$0.26

-50.6%

NASDAQ · Mkt cap $2.3 M

No news headlines were found in the last 48 hours, making it impossible to identify a specific catalyst for the 50.57% single-day drop in ADTX stock price.

The absence of any news in the provided Reuters and Yahoo Finance feeds over the past two days means we cannot connect this dramatic sell-off to an earnings miss, regulatory action, clinical trial failure, or other event-driven catalyst. For a microcap biotech or life sciences company like Aditxt, typical drivers of severe single-day declines include clinical trial setbacks, FDA rejection, patent loss, insider selling disclosure, failed partnership announcements, or dilutive financing news. The stock's extremely low price of $0.25 suggests it may trade with high volatility and lower liquidity, which can amplify intraday moves on lower trading volume or technical breaks. Without access to current news, company filings, or insider transaction reports, we cannot determine whether this represents fundamental bad news, a technical breakdown, or market-driven repricing.

ENHA

Enhanced Group Inc. Class AConsumer Defensive

$3.03−$2.33

-43.5%

NYSE · Mkt cap $252 M

ENHA plunged 43.5% despite announcing $32 million in sponsorship deals for its inaugural Enhanced Games event, suggesting investor disappointment with the deal value or broader skepticism about the business model rather than negative news.

The single headline reports a positive sponsorship achievement of $32 million for the Enhanced Games held May 24th. This is framed as good news by the company. However, the stock's massive 43.5% decline on the same day the announcement was made indicates the market reacted negatively. Possible explanations include: investors expected significantly higher sponsorship revenue and viewed $32 million as underwhelming for a flagship inaugural event; the market may doubt the sustainability or profitability of the Enhanced Games concept itself; there could be undisclosed bad news, earnings disappointment, or guidance cuts released simultaneously with or before this headline; or the announcement merely coincided with a broader market rotation out of speculative sports/entertainment plays. Without access to the full press release, earnings report, or other concurrent news, the gap between the positive headline and the severe selloff remains unexplained by the provided evidence.

YYGH

YY Group Holding LimitedIndustrials

$0.24−$0.14

-37.1%

NASDAQ · Mkt cap $4.5 M

YY Group announced a strategic partnership with Velobotics for autonomous facility management in Southeast Asia, but this positive news failed to prevent a 37% single-day collapse, suggesting the decline was likely driven by factors unrelated to the headline or by broader market/company distress.

The only headline provided announces a partnership expansion into autonomous facility management, which would typically be viewed as a positive development for a workforce management and IFM provider. Yet the stock fell 37% the same day, ranking as the third-worst performer on NASDAQ. This severe disconnect between neutral-to-positive news and catastrophic price action suggests the decline was either triggered by material information not captured in the headlines provided, deteriorating fundamentals revealed in a filing or earnings report, a short squeeze reversal, technical breakdown through key support levels, or broader delisting/financial distress concerns. For a microcap trading at $0.24, liquidity events and sentiment shifts can be extreme. Without access to earnings, SEC filings, trading volume data, or additional news, the specific trigger cannot be definitively identified from the evidence presented.

GMM

Global Mofy Metaverse LimitedTechnology

$0.18−$0.09

-32.5%

NASDAQ · Mkt cap $5.3 M

Global Mofy announced an $8 million registered offering on May 26, which likely triggered a 32.5% drop due to shareholder dilution concerns, despite positive AI platform and regulatory milestone announcements on the same day.

The company released three pieces of news on May 25-26: positive developments around its Gausspeed AI platform integration with NVIDIA Omniverse, CEO participation in China's AI video production standards, and crucially, the closing of an $8 million registered offering. In microcap stocks trading at $0.18, registered offerings typically result in significant share dilution that weighs heavily on existing shareholders. While the platform advancement and regulatory recognition are nominally positive, they appear to have been overwhelmed by dilution concerns. The timing of all three announcements on the same day makes it difficult to isolate which drove the move, but registered offerings historically trigger sharp sell-offs in this market segment regardless of concurrent company milestones. The 32.5% single-day drop is consistent with dilution-driven selling pressure in low-priced equities.

CRBP

Corbus Pharmaceuticals Holdings, Inc.Healthcare

$7.91−$3.44

-30.3%

NASDAQ · Mkt cap $195 M

Corbus Pharmaceuticals dropped 30% despite announcing positive Phase 1/2 clinical data for CRB-701 showing a 42.9% response rate in second-line oropharyngeal and cervical cancers, suggesting the market expected stronger efficacy or had concerns unaddressed by the headline.

The single headline reports clinical progress that the company frames as affirming its strategy and providing an attractive commercial path. A 42.9% objective response rate in a second-line oncology indication is generally considered meaningful; however, the stock's severe decline indicates the market either (1) had set expectations higher before the data release, (2) has concerns about comparator efficacy, durability of response, or safety data not fully captured in the headline, or (3) is reacting to forward guidance or commercial viability assessments embedded in the full press release or conference call that were not captured in this snippet. Without access to the complete announcement, competitive context, or management commentary, we cannot definitively establish whether the data itself was disappointing or whether other factors (capital raise, pipeline delays, valuation reset) triggered the sell-off.

PTIX

Protagenic Therapeutics, Inc.Healthcare

$0.47−$0.18

-28.4%

NASDAQ · Mkt cap $652 K

No news headlines were found in the last 48 hours, so the 28% drop cannot be attributed to a specific announced event; the decline likely reflects technical selling, sector headwinds, or undisclosed developments in a small-cap biotech stock.

Protagenic Therapeutics is a small-cap biotechnology company, a category highly sensitive to clinical trial results, regulatory decisions, financing announcements, and sector sentiment shifts. The absence of any Yahoo Finance headlines in the last 48 hours means the driver of this sharp 28% intraday loss is not a major public announcement captured by standard news feeds. This does not rule out material events: a clinical setback, an internal financing round dilution, late-breaking regulatory news, or a negative analyst note may have circulated through financial networks without yet appearing in headline aggregators, or the move may be purely technical in nature—a forced liquidation, options-related hedging, or sector rotation out of biotech. Without access to real-time trading data, insider filings, or proprietary news sources, attribution remains speculative.

PLYX

Polaryx Therapeutics, Inc. Common StockHealthcare

$2.58−$1.02

-28.3%

NASDAQ · Mkt cap $105 M

No news headlines were available in the last 48 hours, so the 28% drop cannot be directly attributed to a reported event. The decline may reflect delayed market reaction to prior news, a clinical setback, or general biotech sector weakness.

With no recent news in the provided feed, the cause of Polaryx's sharp 28% decline remains unconfirmed by the headlines available. Biotech stocks of this size and market cap typically move on clinical trial results, FDA decisions, financing announcements, or partnership developments. It is possible that material news was released earlier than the 48-hour window, or that the decline stems from sector-wide pressure affecting small-cap therapeutics. Without access to the actual headlines or company filings, any specific attribution would be speculation. The rank as the 7th biggest loser suggests this was a market-wide trading day, which could indicate company-specific bad news rather than general index decline.

SEGG

Sports Entertainment Gaming Global CorporationConsumer Cyclical

$1.40−$0.51

-26.7%

NASDAQ · Mkt cap $8.4 M

No news headlines were found in the last 48 hours, so the 26.70% drop cannot be directly attributed to a disclosed event. The decline likely reflects either a delayed market reaction to an older announcement, technical selling pressure, or undisclosed developments.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for SEGG's sharp 26.70% decline on May 26, 2026. For a micro-cap gaming and entertainment stock like this, price movements of this magnitude can stem from several sources even without fresh headlines: delayed digestion of older earnings misses or guidance cuts, technical breakdown through support levels triggering algorithmic selling, changes in sector sentiment affecting small-cap gaming stocks broadly, or material news released through channels not captured in the Yahoo Finance RSS feed (direct company releases, regulatory filings, or insider transactions). Without access to intraday context or social media activity, we cannot distinguish among these possibilities.

RMSG

Real Messenger CorporationTechnology

$0.88−$0.31

-26.4%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 26% drop likely reflects either a delayed market reaction to unreported news, technical selling pressure, or a company-specific event that has not yet appeared in public financial feeds.

The absence of any Yahoo Finance headlines in the most recent 48-hour window makes it impossible to identify a direct news catalyst for RMSG's sharp decline. A 26% single-day loss for a sub-dollar stock typically correlates with material negative information, but without access to that information here, the cause remains unknown. For stocks in this price range and liquidity profile, possible explanations include delayed disclosure of earnings misses or guidance cuts, insider selling signals, delisting risk announcements, failed business developments, or technical breakdown in a thinly traded name. None of these can be confirmed from the data provided. It is also possible the decline occurred before relevant news was published, or the news appeared on channels not captured by this RSS feed.

AMST

Amesite Inc.Technology

$1.58−$0.52

-24.8%

NASDAQ · Mkt cap $6.2 M

No news headlines were published in the last 48 hours for AMST, so the 24.76% drop on May 26 cannot be attributed to a specific disclosed event based on available information.

The absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for today's sharp decline. AMST is a small-cap educational technology company, and stocks in this category are typically sensitive to a range of factors including sector rotation, liquidity events, short covering reversals, delayed earnings or guidance announcements, regulatory concerns, or changes in analyst sentiment that may not immediately appear in major news feeds. Without access to press releases, earnings reports, insider trading activity, or market commentary from the relevant timeframe, any explanation would be speculative. The magnitude of the move (nearly 25%) suggests either a material negative development or a technical/sentiment shift, but the specific nature cannot be determined from the available evidence.

NAKA

Nakamoto Inc.Financial Services

$5.49−$1.74

-24.1%

QNTM

Quantum BioPharma Ltd.Healthcare

$7.05−$2.19

-23.7%

NASDAQ · Mkt cap $23 M

No news headlines were published in the last 48 hours for Quantum BioPharma, so the 23.70% intraday drop cannot be tied to a specific disclosed event. The cause remains unclear without additional reporting.

The absence of news in the Yahoo Finance RSS feed over the past 48 hours means the trigger for this sharp decline is not immediately obvious from public announcements. For a small-cap biotech stock like QNTM, a single-day 23.70% loss typically stems from one of a few catalyst types: clinical trial failure or delay, FDA rejection or guidance surprise, insider selling or dilutive financing announcement, short-squeeze unwinding, or analyst downgrade. Without headline confirmation, we cannot determine which. It is also possible the move reflects a delayed market reaction to news published more than 48 hours ago, or reaction to intraday rumors or social media momentum rather than official corporate disclosure. The lack of recent headlines does not rule out any of these mechanisms.

NIVF

NewGenIvf Group LimitedHealthcare

$0.78−$0.24

-23.0%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours to explain NIVF's 23% decline, so the cause remains unclear without additional context or company announcements.

NewGenIvf Group Limited dropped 23 percent on May 26, 2026, but no relevant news headlines appeared in the Yahoo Finance RSS feed within the preceding 48 hours. This absence of reported catalyst makes the precise trigger difficult to pinpoint. For a fertility-focused biotech or medical services company like NIVF, typical drivers of sharp declines include adverse clinical trial results, regulatory setbacks, shareholder dilution announcements, management changes, loss of contracts, or shifts in reimbursement policy. Alternatively, the move could reflect technical selling pressure, short-covering reversals, or delayed reaction to an older announcement not captured in the recent headline feed. Without contemporaneous news, any explanation remains speculative.

RYOJ

rYojbaba Co., Ltd. Common SharesIndustrials

$3.85−$1.15

-23.0%

NASDAQ · Mkt cap $53 M

RYOJ dropped 23% on May 26 with no news headlines in the last 48 hours, making the specific catalyst unclear. The move likely stems from a company-specific event, sector pressure, or technical selling not yet reflected in major news outlets.

No headlines were available in the last 48 hours to explain RYOJ's 23% decline, which ranks it among the day's fourteen biggest losers. This sharp drop without corresponding public news suggests either delayed news dissemination, an after-hours or pre-market announcement not yet picked up by Yahoo Finance RSS, or a market reaction to information flowing through smaller channels. For a lower-priced stock trading at $3.85, common catalysts include missed earnings or guidance misses, dilutive equity offerings, insider selling, sector-wide pressure in micro-cap or emerging-market equities, or technical breakdown through key support levels. Without verifiable headlines, the cause remains speculative. The stock's profile as a Japanese company (rYojbaba Co., Ltd.) could suggest currency headwinds, but this would typically require corroborating news. Investors should check company filings, earnings calendars, and broader market conditions for the actual trigger.

MTVA

MetaVia Inc.Healthcare

$2.97−$0.88

-22.9%

NASDAQ · Mkt cap $7.6 M

No news headlines were found in the last 48 hours, so the 22.86% drop cannot be attributed to a specific disclosed catalyst. The move likely reflects either a delayed market reaction to older news, technical selling, or an undisclosed event not yet covered by major news outlets.

Without recent news coverage, the cause of MetaVia's sharp 22.86% decline remains unclear. Small-cap stocks like MTVA (trading near $3) can experience outsized moves on relatively low volume when driven by technical factors, short covering reversals, or market-wide sentiment shifts. The absence of headlines in the last 48 hours suggests either the catalyst preceded this timeframe or the event has not yet been picked up by mainstream financial media. Common drivers for small-cap drops of this magnitude include earnings disappointments, insider selling, debt covenant violations, delayed regulatory news, or accumulation of negative sentiment in less-liquid trading. Without specific information about MetaVia's business model, recent quarters, or insider activity, it is not possible to pinpoint which category applies here.

DEVS

DevvStream Corp. Common StockIndustrials

$0.12−$0.04

-22.6%

NASDAQ · Mkt cap $4.8 M

No news headlines were found in the last 48 hours, so the 22.59% decline in DEVS stock cannot be directly attributed to a specific announcement or event based on available evidence.

The absence of recent news headlines makes it difficult to pinpoint the exact catalyst for today's sharp 22.59% drop in DEVS. For a micro-cap stock trading at $0.12, typical drivers of such moves without accompanying news coverage include technical selling or profit-taking following prior rallies, broader sector weakness in technology or streaming-related stocks, changes in short-seller activity or accumulation of negative sentiment, or delayed disclosure of company developments not yet picked up by major news feeds. Penny stocks and very low-priced equities often exhibit high volatility with limited news correlation, and trades at this price level may reflect thin liquidity and wider bid-ask spreads that amplify intraday swings.

MPU

Mega Matrix Corp.Communication Services

$0.42−$0.11

-21.0%

AMEX · Mkt cap $14 M

No news headlines appeared in the last 48 hours, so the 21% drop cannot be directly attributed to a specific announced event; the decline likely reflects technical selling, sector rotation, or unmonitored developments.

MPU fell 21% on May 26 despite zero news coverage in the prior 48 hours according to the Yahoo Finance RSS feed provided. This absence of publicly reported catalysts makes it difficult to pinpoint a cause with confidence. A few plausible explanations emerge: the stock could have experienced technical breakdown after hitting resistance, sector-wide pressure affecting micro-cap equities on AMEX, or a gap down open on news that was not captured by the headline feed (perhaps from after-market announcements or lower-visibility sources). Given that MPU trades at just $0.42 and ranks as a penny stock, these securities are more prone to high volatility, short squeezes unwinding, or accumulation of bad news from non-mainstream channels. Without direct evidence, attributing the move remains speculative.

HDRN

GigCapital7 Corp.Financial Services

$4.11−$1.06

-20.4%

NASDAQ · Mkt cap $132 M

Hadron Energy completed its SPAC merger and began trading on Nasdaq today under ticker HDRN, but the stock fell 20.45%, likely driven by post-merger sell-off pressure typical of blank-check company debuts or investor disappointment with valuation relative to the $31 million raised.

The headline confirms Hadron Energy completed its business combination with GigCapital7 and started trading on Nasdaq today as HDRN. The company is developing a 10-megawatt micro-modular nuclear reactor. While the news itself is factually neutral, SPAC mergers frequently experience significant price declines on or shortly after the trading debut. This pattern typically reflects several dynamics: lockup expiration concerns, dilution from the SPAC process, investor expectations mismatches, or simple profit-taking by SPAC investors who had been holding the blank-check vehicle. Without additional context on valuation metrics, insider trading details, or market conditions for nuclear or energy plays today, we cannot pinpoint whether the decline reflects fundamental disappointment or is purely technical SPAC mechanics. The 20% drop is substantial but not anomalous for a newly public micro-cap in this space.

SUPX

SuperX AI Technology LimitedTechnology

$9.77−$2.49

-20.3%

NASDAQ · Mkt cap $283 M

No news headlines were published in the last 48 hours for SUPX, so the 20% drop cannot be directly attributed to any identified catalyst; the decline likely stems from technical selling, delayed news digestion, or sector-wide pressure in AI stocks.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to a specific earnings miss, product announcement, regulatory action, or guidance change as the driver of this sharp decline. SUPX is a small-cap AI technology stock, a sector known for volatility and sensitivity to both sentiment shifts and liquidity events. The magnitude of the move (20.31%) suggests either a material negative catalyst that has not yet surfaced in mainstream sources, a significant insider or institutional liquidation, or a technical breakdown in support levels that triggered algorithmic selling. It is also possible that the news exists but has not yet propagated to the RSS feed monitored here. Without access to real-time Twitter, press releases, or earnings calendars, we cannot rule out a same-day announcement that drove the move. Alternatively, the decline could reflect sector rotation away from AI stocks or a broader market correction affecting high-beta equities.

MEHA

Functional Brands, Inc. Common StockConsumer Defensive

$0.09−$0.02

-19.7%

NASDAQ · Mkt cap $177 K

No headlines were published in the last 48 hours to explain MEHA's 19.7% decline, so the cause remains unknown; the drop likely stems from technical selling, a delayed announcement, or broader market conditions affecting micro-cap stocks.

Yahoo Finance returned no headlines for MEHA in the past 48 hours, leaving no news-based explanation for the sharp single-day drop. Functional Brands is a micro-cap stock trading at $0.09, making it highly susceptible to technical factors, including stop-loss cascades, short liquidations, and low-volume price swings that can amplify intraday moves. For stocks in this valuation range, moves of this magnitude often reflect illiquidity and retail-driven volatility rather than fundamental news. Without access to premarket announcements, earnings surprises, SEC filings, or trading halts, the specific catalyst cannot be identified. Possibilities include an unindexed news event, a rumor circulating on social media, or a sector-wide selloff in functional food or beverage companies that has not yet been picked up by mainstream financial media.

STKH

Steakholder Foods Ltd.Consumer Defensive

$1.26−$0.30

-19.2%

NASDAQ · Mkt cap $2.1 M

No news headlines are available from the last 48 hours, so the 19.23% intraday drop cannot be attributed to a specific announced event. The decline likely reflects either a delayed market reaction to prior news, technical selling, or a company-specific development not yet picked up by financial n…

Steakholder Foods is a small-cap food company trading at $1.26, and the absence of recent headlines despite a sharp 19% single-day decline is noteworthy. For a stock of this size and price level, catalysts typically include quarterly earnings reports, changes in executive leadership, material contract losses or gains, regulatory actions affecting food safety or labeling, or shifts in retail distribution. Without news in the RSS feeds provided, the move could reflect a delayed market reaction to news released more than 48 hours ago, technical breakdown through a support level, insider selling, a guidance warning via after-hours filing, or trading driven by short-squeeze reversal or algorithmic rebalancing. The lack of visible news coverage does not rule out a material corporate event occurring outside normal news cycle timing.

DBGI

Digital Brands Group, Inc.Consumer Cyclical

$0.29−$0.07

-19.2%

NASDAQ · Mkt cap $6.8 M

No news headlines were found in the last 48 hours for DBGI, so the 19.20% drop cannot be attributed to a specific announced event; the decline likely reflects technical selling, market conditions affecting micro-cap stocks, or an untracked development.

The absence of any Yahoo Finance headlines in the 48-hour window preceding this sharp 19.20% loss is notable. For a micro-cap stock trading at $0.29 on NASDAQ, price swings of this magnitude can occur without major news coverage, particularly if the move is driven by technical factors such as option expiration, short covering reversal, or algorithmic selling in low-volume sessions. Alternatively, the stock may have experienced a delayed disclosure (not yet indexed by the RSS feed), an earnings miss, a guidance warning, a failed clinical trial if it has healthcare exposure, or deteriorating fundamentals that warranted an intraday washout. Without substantive headlines or knowledge of DBGI's specific business, sector, or recent catalyst history, pinpointing the true driver is not possible from the data at hand.

HAO

Haoxi Health Technology LimitedCommunication Services

$1.09−$0.25

-18.7%

NASDAQ · Mkt cap $1.4 M

HAO dropped 18.66% with no news headlines in the last 48 hours, making it difficult to pinpoint a specific catalyst; the move may reflect technical selling, a delayed announcement, or sector headwinds in healthcare technology stocks.

No recent news headlines are available to explain HAO's sharp 18.66% decline on May 26, 2026. Without access to earnings reports, regulatory filings, management guidance changes, or other event-driven catalysts from the last two days, determining the root cause requires inference. A micro-cap healthcare technology stock like Haoxi Health could experience large single-day moves from several sources: technical breakdown below a key support level, short covering or profit-taking after a prior run, sector-wide weakness in health tech, a delayed earnings miss or guidance cut reported through channels not captured in the RSS feed provided, or unconfirmed rumors circulating in retail or institutional circles. Without headline confirmation of any of these, any explanation remains speculative.

SOXS

Direxion Daily Semiconductor Bear 3X ETF

$6.29−$1.44

-18.6%

AMEX

No news headlines were found in the last 48 hours, but SOXS is a 3X inverse semiconductor ETF that would fall sharply if the underlying semiconductor index rallied significantly, suggesting a strong move up in chip stocks likely drove this decline.

No recent news was provided in the search results for the past 48 hours, so we cannot point to a specific corporate announcement or market event from headlines. However, SOXS is structurally a leveraged inverse ETF designed to move three times opposite the daily performance of semiconductor stocks. An 18.63% decline in SOXS almost certainly reflects a substantial rally in the underlying semiconductor index. This type of move is consistent with broad semiconductor sector strength, which could stem from multiple catalysts such as positive earnings surprises from major chip manufacturers, favorable industry guidance, AI-related optimism, or positive macroeconomic data that boosts risk appetite. Without specific headlines, we cannot identify which of these categories drove the move, only that semiconductor equities moved significantly higher on the day.

OCTVV

Octave Intelligence plcTechnology

$17.76−$3.99

-18.3%

NASDAQ · Mkt cap $4.4 B

Octave Intelligence fell 18.34% following its recent Nasdaq Stockholm listing on May 25, likely driven by post-spinoff volatility, limited financial transparency concerns raised in analyst commentary, and typical uncertainty surrounding newly listed subsidiary equities.

The stock declined sharply on May 26, the day after Octave Intelligence's official listing on Nasdaq Stockholm following its spinoff from Hexagon AB on April 24. The timing strongly suggests the drop reflects post-IPO price discovery and adjustment rather than a discrete negative catalyst. However, a May 26 analyst note explicitly flagged financial transparency as limited, which may have contributed to selling pressure as investors reassessed the investment case. New spinoffs commonly experience volatility in their first weeks of trading as the market reprices the separated entity without its parent's implicit support or consolidated financial profile. The 18% single-day decline is material but not extraordinary for newly independent securities encountering real-money portfolio adjustments and liquidity discovery.

VRAX

Virax Biolabs Group LimitedHealthcare

$0.23−$0.05

-18.2%

NASDAQ · Mkt cap $2.5 M

Virax announced positive early clinical data for its Long COVID test on the same day the stock fell 18%, suggesting investors either expected stronger results, have concerns about the commercial viability despite positive data, or the market reacted to other undisclosed factors unrelated to the h…

The company released what it characterizes as positive early pilot performance data for ViraxImmune, a blood-based diagnostic test for Long COVID and post-acute infection syndromes. This is normally the type of news that would support a stock price, particularly for a biotech firm with a clinical-stage asset. However, the stock dropped sharply on the day of the announcement. This disconnect suggests either the market found the data underwhelming relative to prior expectations, investors questioned the path to commercialization or reimbursement for a Long COVID diagnostic, or external factors such as sector rotation, portfolio repositioning, or broader market conditions drove the decline independent of the news content itself. Without access to the full clinical data release, details on trial design, or analyst commentary, it is difficult to assess whether the "positive" characterization matches market expectations.

VMAR

Vision Marine Technologies Inc.Consumer Cyclical

$0.55−$0.11

-17.2%

NASDAQ · Mkt cap $4.6 M

Vision Marine Technologies fell 17.17% following an operational update on its Nautical Ventures platform released on May 25, though the headline text provided does not specify the nature or quality of that update, making the direct link to the sell-off unclear.

The only substantive news item in the past 48 hours is an operational update on the Nautical Ventures platform announced on May 25 at 20:30 UTC, which would have reached the market before this snapshot. However, the headline excerpt provided does not contain the actual content of that update—only a generic description that the company is combining electric marine propulsion with vertically integrated retail and service. Without knowing whether the update contained disappointing metrics, reduced guidance, delays, funding needs, or other negative information, it is impossible to confirm causation. For a micro-cap marine technology company trading at $0.55, typical sell-offs can also stem from broader liquidity concerns, insider selling, dilutive financing announcements, or technical breakdown in a thinly traded stock. The second headline about upcoming meeting dates appears unrelated to the price action.

AMSS

AMASS Brands Inc. Common StockConsumer Defensive

$3.58−$0.74

-17.1%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours, so the 17.13% drop cannot be directly attributed to a disclosed event. The decline likely reflects either delayed market reaction to earlier developments, technical selling, or undisclosed company news.

The absence of recent headlines in the news feed creates a significant information gap. A 17.13% single-day drop is substantial and typically warrants a material catalyst, yet none is evident in the provided sources. This could indicate several possibilities. First, negative news may have been released but not yet aggregated into the Yahoo Finance RSS feed used here, creating a timing lag. Second, the stock could be experiencing technical selling pressure or profit-taking unrelated to company-specific news. Third, for smaller-cap or lower-liquidity stocks like AMASS, price swings can be amplified by thin trading volumes. Without access to earnings reports, guidance changes, regulatory filings, or management announcements from the snapshot date itself, attributing causation to a specific event is not possible based on the evidence provided.

PYXS

Pyxis Oncology, Inc.Healthcare

$1.63−$0.33

-16.8%

NASDAQ · Mkt cap $214 M

No news headlines were found in the last 48 hours, so the 16.84% drop in PYXS cannot be attributed to a specific announced event; the decline likely reflects broader biotech sector weakness, technical selling, or unreported developments.

Pyxis Oncology is a clinical-stage oncology company, and such stocks are inherently volatile and sensitive to clinical trial results, financing developments, partnership news, and sector sentiment. The absence of any Yahoo Finance headlines in the last 48 hours means no major announced catalyst is visible in the provided data. The sharp single-day decline of nearly 17% in a micro-cap biotech stock could reflect several common drivers: unfavorable clinical trial data released outside major news feeds, an announced secondary offering or dilutive financing, loss of institutional support, short covering reversal, or deteriorating sentiment in the broader oncology or biotech sector. Without headline confirmation, these remain plausible categories rather than established facts.

THH

TryHard Holdings LimitedIndustrials

$0.34−$0.07

-16.6%

NASDAQ

No news headlines were published in the last 48 hours for THH, so the 16.64% drop cannot be directly attributed to a reported event. The decline likely reflects either technical selling pressure, market-wide sentiment shifts, or undisclosed company developments.

The absence of any recent news headlines creates a gap between the significant single-day loss and any identifiable public catalyst. For a stock trading at $0.34 on NASDAQ, typical drivers of sharp declines without accompanying news coverage include profit-taking after prior gains, sector rotation out of speculative small-cap positions, negative social media or online discussion not yet reflected in traditional financial news, insider selling announcements, or deteriorating technical chart patterns that prompt mechanical liquidation. Without access to company filings, insider transactions, or broader market context for this particular date, the specific cause cannot be determined from available evidence.

SIMAU

SIM Acquisition Corp. I UnitFinancial Services

$10.91−$2.10

-16.1%

NASDAQ · Mkt cap $335 M

No news headlines were found in the last 48 hours; the 16% drop in SIMAU likely reflects either a market-wide sell-off, deteriorating SPAC merger prospects, or a previously announced but delayed deal update surfacing today.

SIM Acquisition Corp. I Unit is a blank-check company (SPAC) trading near the typical $10 per-share redemption floor. With zero news in the past two days, the sharp decline suggests either a technical or structural trigger rather than breaking news. For SPACs, common catalysts include announcement of a merger target (often causing units to decline if terms disappoint), redemption pressure as deal certainty erodes, or a broader market downturn hitting SPACs disproportionately. The -16% move is severe enough to suggest real event risk rather than random drift, but without headlines we cannot identify the specific trigger. The drop below $10.91 toward redemption value would typically occur if investors are losing confidence in a pending deal or if redemption rates are spiking.

HUIZ

Huize Holding LimitedFinancial Services

$1.47−$0.28

-16.0%

NASDAQ · Mkt cap $13 M

HUIZ dropped 16% on May 26, 2026, but no news headlines were available in the prior 48 hours to identify the specific trigger, leaving the cause unclear without additional market context.

No headlines from Yahoo Finance RSS were found in the last 48 hours to explain the 16% drop in HUIZ stock. This absence of reported news is significant because a move of this magnitude typically correlates with a disclosed event—earnings disappointment, regulatory action, guidance revision, or material business update. For a micro-cap or small-cap healthcare or financial stock like Huize Holding, the catalyst could fall into several categories: delayed disclosure of earnings or financial results, an overnight analyst downgrade not yet captured in the headline feed, insider selling or lockup expiration, or broader market pressure on a specific sector. Without substantive news or structural knowledge about the stock's composition, we cannot distinguish between these possibilities or rule out technical factors like short covering, forced liquidation, or a rumor not yet surfaced in major media.

CRCG

Leverage Shares 2x Long CRCL Daily ETF

$27.31−$5.15

-15.9%

NASDAQ

No news headlines were available in the past 48 hours, but the -15.87% decline in this 2x leveraged ETF tracking CRCL stock likely reflects a sharp drop in the underlying CRCL shares, amplified by the fund's daily leverage mechanics.

No recent news was published in the last 48 hours according to the RSS feed provided, so the specific catalyst for today's decline cannot be identified from headlines. However, this security is a 2x long daily leveraged ETF, meaning it amplifies daily moves in its underlying stock CRCL by approximately two times. A -15.87% drop in the leveraged fund implies roughly an 8% decline in CRCL itself. Without news on the underlying company, the move could stem from several categories: adverse market-wide sentiment affecting CRCL's sector, a delayed announcement or rumor circulating offline, technical selling pressure, or earnings or guidance-related disappointment released outside the monitored RSS window. The leverage structure also means intraday volatility can create tracking drag or rebalancing effects that exacerbate losses on down days.

WKSP

Worksport Ltd.Consumer Cyclical

$0.85−$0.16

-15.7%

NASDAQ · Mkt cap $9.8 M

Worksport announced a new U.S. patent for its ZeroFrost heat pump technology on the morning of the 15.68% decline, but the patent grant itself—a positive development for IP—does not clearly explain why the stock fell sharply the same day.

The only headline provided is a patent issuance announcement for Worksport's ZeroFrost heat pump technology through its Terravis Energy subsidiary. Patent grants are typically viewed as positive catalysts for intellectual property protection and competitive positioning, not negative ones. The timing of the announcement (12:15 UTC on the same day as the decline) rules out a delayed reaction to older news. The disconnect between bullish news (new patent) and a sharp bearish price action suggests either (1) the market is repricing the stock on unrelated negative sentiment, sector weakness, or broader market conditions not reflected in the headlines provided, (2) there is material news not captured in the RSS feed, or (3) technical or liquidity factors drove the decline independent of fundamental catalysts. Without additional context on market conditions, insider activity, or competing headlines, the cause remains unclear.

GEMG

Leverage Shares 2x Long GEMI Daily ETF

$11.88−$2.19

-15.6%

NASDAQ

No news headlines were found in the last 48 hours, but GEMG is a 2x leveraged ETF tracking GEMI, so a sharp daily decline most likely reflects a significant drop in the underlying index or equity it tracks, amplified by the 2x leverage structure.

The absence of any news headlines in the last 48 hours makes it impossible to pinpoint a specific company announcement, earnings surprise, or market event as the direct cause. However, GEMG is a leveraged daily ETF with 2x exposure to GEMI, which means its daily performance is mechanically amplified relative to its underlying index or benchmark. A -15.58% decline in a 2x long product typically implies the underlying asset fell roughly 7-8% on the day, or accumulated losses over multiple days in a downtrend. Common catalysts for such underlying declines include broad sector selloffs, index rebalancing, changes in investor sentiment toward the GEMI constituents, or delayed news that moved markets before this snapshot date. Without headlines or visibility into GEMI's composition and recent price action, the precise trigger remains unknown, but leverage amplification of the underlying's move is the structural explanation.

EDHL

Everbright Digital Holding Limited Ordinary SharesCommunication Services

$2.57−$0.46

-15.2%

NASDAQ · Mkt cap $6.5 M

No news headlines are available for the last 48 hours to explain Everbright Digital's 15.18% drop on May 26, 2026, making it impossible to identify the specific catalyst from public announcements.

The absence of any news coverage in the provided data means we cannot point to a concrete event such as earnings disappointment, guidance cut, regulatory action, or market development. For a stock experiencing such a sharp single-day decline ranking as the 36th biggest loser, typical catalysts would include negative earnings surprises, insider selling, sector rotation, short seller activity, or a missed business milestone. Without headlines or structural context about Everbright Digital's business model, leverage profile, or recent trading dynamics, it is impossible to distinguish between technical selling, delayed news absorption from earlier announcements, a broad market sector rotation, or company-specific negative developments that simply were not captured in the RSS feed provided.

CDT

CDT Equity Inc.Healthcare

$0.88−$0.16

-15.0%

Horizon Quantum Holdings Ltd. Class A Ordinary SharesTechnology

$11.84−$2.06

-14.8%

NASDAQ · Mkt cap $905 M

Quantinuum's upcoming IPO announcement may have triggered profit-taking and sector rotation away from smaller quantum software players like HQ, or investors are reassessing the competitive landscape as a larger, Honeywell-backed rival prepares to enter the public markets.

The timing is suggestive but not conclusive. HQ dropped 14.82% on the same day Quantinuum's IPO terms were announced—a much larger, better-capitalized competitor backed by industrial giant Honeywell. The May 25 headline emphasizing HQ's software-focused strategy and hardware-agnostic platform positioning is neutral and does not signal negative news about HQ itself. However, in speculative sectors like quantum computing, the arrival of a heavyweight competitor can spark rotation out of smaller pure-play names, particularly if investors view Quantinuum as having superior resources and market access. This is reasonable inference rather than established cause, as no specific HQ-related negative catalyst appears in the news provided. Market psychology and competitive positioning concerns are plausible drivers for this tier of stock.

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$2.93−$0.51

-14.7%

NASDAQ · Mkt cap $6.9 M

No news headlines were found in the last 48 hours, so the 14.70% single-day drop likely reflects either a delayed market reaction to an earlier announcement, broad sector weakness, or a company-specific rumor not yet captured in major news feeds.

The absence of any news headlines in the 48-hour window preceding this sharp decline makes it impossible to identify a specific catalyst from the evidence provided. A drop of this magnitude—ranking SUGP 39th among the day's losers—typically correlates with material corporate announcements (earnings misses, guidance cuts, insider selling disclosures, debt defaults, or regulatory issues), sector-wide selloffs, or significant negative rumors circulating on social media or institutional networks before formal press releases. Without access to the company's recent SEC filings, earnings calendar, or social media sentiment data, we cannot distinguish between these scenarios. It is also possible this represents a delayed reaction to news released before the 48-hour window, or a technical/liquidity-driven move unrelated to fundamentals.

CAST

FreeCast, Inc. Class A Common StockCommunication Services

$0.86−$0.15

-14.7%

NASDAQ · Mkt cap $100 M

FreeCast announced a partnership with FPUnet to bring streaming services to 30,000 homes in Fort Pierce, but the market sold off 14.69% anyway, suggesting the deal size or terms disappointed investors relative to expectations.

The news headline is positive in tone—a partnership expansion that adds distribution to 30,000 households and highlights streaming and FAST channel access through a fiber provider. However, the stock fell sharply on the same day the news was released. This disconnect suggests either the deal was already priced in and investors expected larger terms, or the market viewed 30,000 homes as insufficient to move the needle for a company trading at $0.86 with likely limited scale. Alternatively, the timing and nature of the deal could signal weaker organic growth or difficulty achieving traction without external partnerships. Micro-cap stocks like FreeCast are sensitive to sentiment shifts; even positive announcements can trigger selling if they fail to demonstrate material revenue impact or signal desperation to find distribution channels.

SNAL

Snail, Inc. Class A Common StockCommunication Services

$0.94−$0.16

-14.5%

NASDAQ · Mkt cap $26 M

No news headlines were published in the last 48 hours for SNAL, so the 14.55% decline cannot be attributed to a specific announced event. The move likely reflects technical selling, a delayed market reaction to older news, or sector-wide pressure.

The absence of any recent headlines in the provided data makes it impossible to pinpoint a definitive cause for today's 14.55% drop in SNAL stock. Possible explanations fall into several categories: the stock may have reacted to news or regulatory filings released outside the 48-hour window; broader NASDAQ weakness or sector-specific headwinds may have pressured a smaller-cap name; technical factors such as stop-loss cascades or options expiration effects could have driven intraday selling; or the move could reflect accumulating negative sentiment from earlier announcements or earnings misses that have now crystallized into selling pressure. Without access to the company's recent earnings, guidance, clinical trial data (if biotech), or other material disclosures, we cannot distinguish among these possibilities.

SDST

Stardust Power Inc.Industrials

$2.27−$0.38

-14.3%

NASDAQ · Mkt cap $8.6 M

No news headlines were published in the last 48 hours, so the cause of the 14.34% decline cannot be determined from available reporting. The drop may reflect technical selling, sector weakness, or unreported company developments.

The absence of any news in the Yahoo Finance RSS feed over the past two days means the headline-driven catalyst for this sharp 14.34% decline cannot be identified from public reporting. For a microcap name like Stardust Power trading at $2.27, typical drivers of significant single-day moves include missed earnings or earnings surprises, updates to contracts or revenue guidance, sector rotation out of alternative or renewable energy plays, short-squeeze unwinding, or technical support breaks. Without access to press releases, earnings calendars, or social media sentiment, it is not possible to determine which of these (or another catalyst entirely) triggered the decline. The stock's ranking as the 42nd biggest loser suggests the move was substantial but not tied to a visible headline event on the major news wire.

EHGO

Eshallgo Inc. Class A Ordinary SharesIndustrials

$1.70−$0.28

-14.1%

SLXN

Silexion Therapeutics Ltd.Healthcare

$0.43−$0.07

-14.1%

NASDAQ · Mkt cap $540 K

Silexion announced a 1-for-10 reverse split effective May 29, which typically signals financial distress and compliance struggles, likely triggering the 14% single-day drop as investors price in dilution risk and delisting concerns.

The reverse split announcement is the only news provided and directly correlates with the timing of the decline. Reverse splits are commonly perceived negatively by markets because they indicate a company struggling to maintain minimum stock price requirements for exchange listing—in this case, Nasdaq compliance. While management framed the split as helping market position and development progress, investors typically interpret such moves as a red flag for financial weakness or potential dilution ahead. The stock is already trading at $0.43, suggesting it was already in distress before the announcement. The split itself doesn't change fundamentals but signals underlying problems. Without additional context on cash runway, clinical trial progress, or burn rate, the market appears to have reacted to the structural signal rather than fundamental news.

CAPS

Capstone Holding Corp.Basic Materials

$0.32−$0.05

-14.1%

NASDAQ · Mkt cap $2.9 M

No news headlines appeared in the last 48 hours, so the 14% decline likely reflects either technical selling, delayed market reaction to an earlier event, or sector-wide pressure on micro-cap stocks.

The absence of recent news makes it impossible to pinpoint a specific catalyst for CAPS's 14.1% single-day drop. For a stock trading at $0.32 on NASDAQ, typical movers include sharp reversals in micro-cap or penny-stock trading patterns, delayed reactions to earnings or guidance misses from prior days, broad sector rotation affecting small industrials or specialty firms, or reaction to insider news not yet reflected in public headlines. Without access to intraday volume data, trading patterns, or sector context for Capstone Holding, we cannot rule out technical factors such as short covering reversals, margin-related liquidation, or the stock falling below a key support level. A comprehensive search of regulatory filings or company-specific news sources beyond the 48-hour window might reveal the triggering event.

DAO

Youdao, Inc.Consumer Defensive

$11.14−$1.82

-14.0%

NYSE · Mkt cap $1.8 B

No relevant news headlines were provided to explain DAO's 14% decline. The stock drop likely reflects sector rotation, profit-taking, or company-specific factors not captured in the available information.

The single headline provided is a generic market commentary piece about growth companies with high insider ownership and 20% revenue growth, published on May 25. It does not mention DAO, Youdao, or any specific company catalyst. The headline discusses broader market conditions (US market up 1.1% over 7 days, up 29% over a year) which would typically support equity valuations rather than explain a sharp single-stock decline. DAO's 14% loss on May 26 is material and ranks it among the day's biggest losers, yet no earnings release, guidance change, product announcement, regulatory action, or company-specific news is visible in the provided data. Possible explanations for Youdao specifically could include quarterly earnings disappointment, declining user metrics, competitive pressure in China's education tech sector, or macroeconomic headwinds affecting Chinese tech stocks generally, but none of these are confirmed by the available headlines.

DXF

Eason Technology LimitedFinancial Services

$0.65−$0.10

-13.9%

AMEX · Mkt cap $1.6 M

No relevant news headlines explain DXF's 13.86% decline. The provided headline about Asian ADRs rising broadly contradicts the stock's sharp drop, suggesting the sell-off was driven by company-specific or technical factors unrelated to the market backdrop.

The single headline provided mentions that Asian equities trading as American Depositary Receipts rose sharply on Tuesday morning, which is a tailwind for stocks like DXF. Yet DXF fell 13.86% and ranked among the day's biggest losers, creating a disconnect. This suggests the decline was not driven by broad ADR weakness or macro conditions. Possible explanations for a single-day plunge of this magnitude in a micro-cap stock typically include: a negative earnings or financial update not captured in the 48-hour window; insider selling or lockup expiration; a delisting warning; a failed capital raise or dilutive offering; or short-seller pressure. Without access to company-specific news, financial releases, or regulatory filings, we cannot pinpoint which category applies here.

BTGO

BitGo Holdings, Inc.Financial Services

$5.97−$0.96

-13.9%

NYSE · Mkt cap $883 M

No news headlines were found in the last 48 hours, so the 13.85% drop in BTGO cannot be directly attributed to any announced event. The decline likely stems from broader crypto market weakness, technical selling, or unannounced corporate developments.

The absence of any news coverage in the last 48 hours means we cannot point to a specific catalyst such as earnings, guidance changes, regulatory action, or business announcements. BitGo is a cryptocurrency custody and infrastructure provider, making it highly sensitive to crypto market sentiment and Bitcoin price movements. A decline of this magnitude could reflect several plausible drivers: a sharp downturn in crypto assets or market confidence, technical weakness from investors taking profits after a run-up, short covering, or negative commentary from industry insiders that hasn't yet appeared in formal headlines. Without supporting news, the move appears either driven by broader sectoral headwinds affecting digital asset companies or by events not yet captured in public financial news feeds.

CELG-RI

Bristol-Myers Squibb Company Ce

$0.09−$0.01

-13.8%

RPGL

Republic Power Group Limited Class A Ordinary SharesTechnology

$0.25−$0.04

-13.8%

NASDAQ · Mkt cap $2.6 M

Republic Power Group announced a 1-for-40 reverse share split on May 26, which typically signals financial distress or low stock price remediation and likely triggered the 13.79% same-day decline as the market repriced the stock post-split.

A reverse share split consolidates existing shares at a ratio intended to raise the per-share price while reducing share count. RPGL announced a 1-for-40 reverse split on the snapshot date itself. This is a structural action typically undertaken by distressed companies, those at risk of delisting, or firms seeking to reset valuation optics. While the split mechanically does not change shareholder ownership percentage, market participants often interpret reverse splits negatively because they signal underlying business challenges or prior sharp share-price decline. The 13.79% drop on the announcement day is consistent with this perception—investors may be reacting to the implied weakness the split announcement conveys, rather than to any fundamental deterioration in earnings or contracts announced separately.